SCHEMBL7658552

SCHEMBL7658552

O=C(c1cncc(C(=O)N(CC(CO)CO)CC(CO)CO)c1)N(CC(CO)CO)CC(CO)CO

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 3/20 0.34
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MLYCD O95822 2/20 0.32
HCAR2 Q8TDS4 4/20 0.32
POLB P06746 1/20 0.32
LMNA P02545 1/20 0.32
DDO Q99489 1/20 0.32
CFTR P13569 1/20 0.31
NTRK2 Q16620 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656151 0.84 CASP3 (0.34) CASP3CYP2C9CYP2C19KDM4EALDH1A1
SCHEMBL7654546 0.83 KMT2A (0.38) CASP3CYP2C9CYP2C19KDM4EALDH1A1
SCHEMBL7108508 0.79
SCHEMBL7650135 0.76 NTRK2 (0.44) CASP3CYP2C9CYP2C19KDM4EALDH1A1
SCHEMBL7109261 0.74 MLYCD (0.31) ALDH1A1MLYCDL3MBTL1
SCHEMBL7658682 0.73 MLYCD (0.43) KDM4EALDH1A1MLYCDCFTRL3MBTL1
SCHEMBL7651968 0.71 KDM4E (0.40) CYP2C9CYP2C19KDM4EALDH1A1MEN1
SCHEMBL7659400 0.71 AKR1C3 (0.39) CYP2C9CYP2C19KDM4EALDH1A1MEN1
SCHEMBL2781653 0.70 ROCK1 (0.37) CASP3CYP2C9CYP2C19KDM4EALDH1A1
SCHEMBL7662443 0.70 KMT2A (0.36) CYP2C9CYP2C19KDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed